- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00792597
Comparison of Three Methods of Hemoglobin Monitoring
March 6, 2013 updated by: University of California, San Francisco
Comparison of Three Methods of Hemoglobin Monitoring in Patients Undergoing Spine Revision or Hip Revision Surgery.
The purpose of this study is to compare the hemoglobin results obtained with 1) the HemoCue™, 2) the Masimo SpHb™, and 3) the UCSF Clinical Laboratory.
The goal is to determine if these three values differ from each other during various levels of blood loss in the clinical care of patients for spine revision and hip revision surgery.
Study Overview
Status
Completed
Conditions
Detailed Description
See above
Study Type
Observational
Enrollment (Actual)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Francisco, California, United States, 94143
- University of California San Francisco
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
See inclusion/exclusion criteria
Description
Inclusion Criteria:
- Male or non-pregnant female 18 y/o or older
- American Society of Anesthesiology Classification 1, 2 or 3
- Scheduled to undergo spine or hip revision surgery
Exclusion Criteria:
- Pregnant or nursing
- Patients who in the study investigators clinical judgement would not be suitable for research.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
spine or hip surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
See description below
Time Frame: A minimum of three differences recorded during surgery
|
Primary outcome is based on the difference between SpHb (Masimo SpHb™ continuous hemoglobin reading ) - tHb (laboratory hemoglobin determination).
|
A minimum of three differences recorded during surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
See description below
Time Frame: A minimum of three differences recorded during surgery
|
Secondary outcome is based on the difference between a HemoCue™ derived hemoglobin determination - laboratory hemoglobin determination.
|
A minimum of three differences recorded during surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Ronald D Miller, MD, University of California, San Francisco
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2009
Primary Completion (Actual)
April 1, 2010
Study Completion (Actual)
December 1, 2010
Study Registration Dates
First Submitted
November 14, 2008
First Submitted That Met QC Criteria
November 17, 2008
First Posted (Estimate)
November 18, 2008
Study Record Updates
Last Update Posted (Estimate)
March 7, 2013
Last Update Submitted That Met QC Criteria
March 6, 2013
Last Verified
March 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10-00524
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Loss
-
The University of Texas Health Science Center at...RecruitingMyomectomy; Surgical Blood LossUnited States
-
Assiut UniversityCompletedHepatectomy, Surgical Blood Loss, TerlipressinEgypt
-
CSL BehringCompletedSurgical Blood Loss | Postoperative Blood LossUnited Kingdom, Canada, Japan, Italy, Poland, Germany, Czech Republic, Austria, Brazil, Denmark, Finland
-
Population Health Research InstituteCompletedBleeding | Surgical Blood LossCanada
-
Northwell HealthCompletedSurgical Blood LossUnited States
-
i-SEPCompletedHemorrhage | Blood Loss | Surgical Blood LossFrance
-
Henry Ford Health SystemCompletedBlood Loss, Surgical | Blood Loss AnemiaUnited States
-
Kasr El Aini HospitalRecruitingTo Calculate Total Blood Loss Immediately PostoperativeEgypt
-
Population Health Research InstituteTerminatedBleeding | Seizures | Surgical Blood LossNew Zealand, Canada, China, Malaysia, Czechia, Russian Federation
-
University Health Network, TorontoThe Physicians' Services Incorporated FoundationCompletedTotal Knee Arthroplasty | Surgical Blood LossCanada